Excepgen Patents

Patent portfolio assigned to Excepgen (verified via public assignee records). Estimated patent count: 2. Protein expression tech (engineered human cell line) for drug discovery; YC-backed. AstraZeneca named as a pharma partner in press; two other Big Pharma partners unnamed. ExcepGen Inc is listed as assignee on protein-expression patents (US20240141373A1, AU2020351130A1).